Inflammatory and growth factor response to continuous and intermittent exercise in youth with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 11, Issue 2, 2012, Pages 108-118

  Nguyen, Thanh ^a   Obeid, Joyce ^a   Ploeger, Hilde E ^a,b   Takken, Tim ^a,c   Pedder, Linda ^d   Timmons, Brian W ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d MCMASTER CHILDREN S HOSPITAL   (Canada)

Author keywords

Cytokines; High intensity; Immune cells; Moderate intensity; TWEAK

Indexed keywords

GROWTH HORMONE; INTERLEUKIN 6; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CHILD; CHRONIC INFLAMMATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXERCISE; EXERCISE INTENSITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; LEUKOCYTE; LUNG FIBROSIS; LYMPHOCYTE; MALE; MONOCYTE; NEUTROPHIL; OUTCOME ASSESSMENT; REST; SCHOOL CHILD;

ADOLESCENT; CHILD; CYSTIC FIBROSIS; EXERCISE; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-6; MALE; NEUTROPHILS; TUMOR NECROSIS FACTOR-ALPHA; TUMOR NECROSIS FACTORS;

EID: 84858292246     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2011.10.001     Document Type: Article

References (53)

1. Tirakitsoontorn P., Nussbaum E., Moser C., Hill M., Cooper D.M. Fitness, acute exercise, and anabolic and catabolic mediators in cystic fibrosis. Am J Respir Crit Care Med 2001, 164:1432-1437.
2. Ionescu A.A., Nixon L.S., Shale D.J. Cellular proteolysis and systemic inflammation during exacerbation in cystic fibrosis. J Cyst Fibros 2004, 3:253-258.
3. Ionescu A.A., Nixon L.S., Evans W.D., Stone M.D., Lewis-Jenkins V., Chatham K., et al. Bone density, body composition, and inflammatory status in cystic fibrosis. Am J Respir Crit Care Med 2000, 162:789-794.
4. Schöni M.H., Casaulta-Aebischer C. Nutrition and lung function in cystic fibrosis patients: review. Clin Nutr 2000, 19:79-85.
5. Howarth K., Burgomaster K., Phillips S., Gibala M. Exercise training increases branched-chain oxoacid dehydrogenase kinase content in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 2007, 293:R1335-R1341.
6. Al-Mousawi A., Williams F., Mlcak R., Jeschke M., Herndon D., Suman O. Effects of exercise training on resting energy expenditure and lean mass during pediatric burn rehabilitation. J Burn Care Res 2010, 31:400-408.
7. Hankard R., Munck A., Navarro J. Nutrition and growth in cystic fibrosis. Horm Res 2002, 58(Suppl. 1):16-20.
8. Gulmans V.A., de Meer K., Brackel H.J., Faber J.A., Berger R., Helders P.J. Outpatient exercise training in children with cystic fibrosis: physiological effects, perceived competence, and acceptability. Pediatr Pulmonol 1999, 28:39-46.
9. Klijn P.H.C., Oudshoorn A., van der Ent C., van der Net J., Kimpen J., Helders P.J.M. Effects of anaerobic training in children with cystic fibrosis: a randomized controlled study. Chest 2004, 125:1299-1305.
10. Selvadurai H.C., Blimkie C.J., Meyers N., Mellis C.M., Cooper P.J., Van Asperen P.P. Randomized controlled study of in-hospital exercise training programs in children with cystic fibrosis. Pediatr Pulmonol 2002, 33:194-200.
11. Wilkes D.L., Schneiderman J.E., Nguyen T., Heale L., Moola F., Ratjen F., et al. Exercise and physical activity in children with cystic fibrosis. Paediatr Respir Rev 2009, 10:105-109.
12. Hong-Brown L., Brown C.R., Cooney R., Frost R., Lang C. Sepsis-induced muscle growth hormone resistance occurs independently of STAT5 phosphorylation. Am J Physiol Endocrinol Metab 2003, 285:E63-E72.
13. Chitnis M., Yuen J.S.P., Protheroe A., Pollak M., Macaulay V. The type 1 insulin-like growth factor receptor pathway. Clin Cancer Res 2008, 14:6364-6370.
14. Velloso C.P. Regulation of muscle mass by growth hormone and IGF-I. Br J Pharmacol 2008, 154:557-568.
15. Schweizer R., Martin D.D., Schönau E., Ranke M.B. Muscle function improves during growth hormone therapy in short children born small for gestational age: results of a peripheral quantitative computed tomography study on body composition. J Clin Endocrinol Metab 2008, 93:2978-2983.
16. Hardin D.S., Ellis K.J., Dyson M., Rice J., McConnell R., Seilheimer D.K. Growth hormone decreases protein catabolism in children with cystic fibrosis. J Clin Endocrinol Metab 2001, 86:4424-4428.
17. De Benedetti F., Alonzi T., Moretta A., Lazzaro D., Costa P., Poli V., et al. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest 1997, 99:643-650.
18. De Benedetti F., Rucci N., Del Fattore A., Peruzzi B., Paro R., Longo M., et al. Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system. Arthritis Rheum 2006, 54:3551-3563.
19. Bodell P.W., Kodesh E., Haddad F., Zaldivar F.P., Cooper D.M., Adams G.R. Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise. J Appl Physiol 2009, 106:443-453.
20. Garca-Martnez C., Lpez-Soriano F.J., Argils J.M. Interleukin-6 does not activate protein breakdown in rat skeletal muscle. Cancer Lett 1994, 76:1-4.
21. Williams A., Wang J.J., Wang L., Sun X., Fischer J.E., Hasselgren P.O. Sepsis in mice stimulates muscle proteolysis in the absence of IL-6. Am J Physiol 1998, 275:R1983-R1991.
22. Ebisui C., Tsujinaka T., Morimoto T., Kan K., Iijima S., Yano M., et al. Interleukin-6 induces proteolysis by activating intracellular proteases (cathepsins B and L, proteasome) in C2C12 myotubes. Clin Sci 1995, 89:431-439.
23. Fan J., Char D., Bagby G.J., Gelato M.C., Lang C.H. Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor. Am J Physiol 1995, 269:R1204-R1212.
24. Frost R., Nystrom G., Lang C. Tumor necrosis factor-alpha decreases insulin-like growth factor-I messenger ribonucleic acid expression in C2C12 myoblasts via a Jun N-terminal kinase pathway. Endocrinology 2003, 144:1770-1779.
25. Fernandez-Celemin L., Pasko N., Blomart V., Thissen J.P. Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-alpha. Am J Physiol Endocrinol Metab 2002, 283:E1279-E1290.
26. Costelli P., Carb N., Tessitore L., Bagby G.J., Lopez-Soriano F.J., Argils J.M., et al. Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest 1993, 92:2783-2789.
27. Chicheportiche Y., Bourdon P.R., Xu H.D., Hsu Y.M., Scott H., Hession C., et al. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 1997, 272:32401-32410.
28. Saitoh T., Yamamoto N., Yamaoka S., Nakayama M., Nakano H., Yagita H. TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation. J Biol Chem 2003, 278:36005-36012.
29. Dogra C., Changotra H., Wedhas N., Qin X., Wergedal J.E., Kumar A. TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine. FASEB J 2007, 21:1857-1869.
30. Xu H., Okamoto A., Ichikawa J., Ando T., Tasaka K., Masuyama K., et al. TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF. Biochem Biophys Res Commun 2004, 318:422-427.
31. Gabriel H., Kindermann W. The acute immune response to exercise: what does it mean?. Int J Sports Med 1997, 18(Suppl. 1):S28-S45.
32. Pedersen B.K., Steensberg A., Schjerling P. Muscle-derived interleukin-6: possible biological effects. J Physiol (Lond) 2001, 536:329-337.
33. Obeid J., Nguyen T., Gabel L., Timmons B.W. Physical activity in Ontario preschoolers: prevalence and measurement issues. Appl Physiol Nutr Metab 2011, 36:291-297.
34. Baquet G., Stratton G., Van Praagh E., Berthoin S. Improving physical activity assessment in prepubertal children with high-frequency accelerometry monitoring: a methodological issue. Prev Med 2007, 44:143-147.
35. Bailey R.C., Olson J., Pepper S.L., Porszasz J., Barstow T.J., Cooper D.M. The level and tempo of children's physical activities: an observational study. Med Sci Sports Exerc 1995, 27:1033-1041.
36. Cooper D. New horizons in pediatric exercise research. New Horizons in Pediatric Exercise Science 1995, 1-24. Human Kinetics, Champaign, IL. C. Blimkie, O. Bar-Or (Eds.).
37. Gibala M., Little J., van Essen M., Wilkin G., Burgomaster K., Safdar A., et al. Short-term sprint interval versus traditional endurance training: similar initial adaptations in human skeletal muscle and exercise performance. J Physiol (Lond) 2006, 575:901-911.
38. Burgomaster K., Howarth K., Phillips S., Rakobowchuk M., Macdonald M., McGee S., et al. Similar metabolic adaptations during exercise after low volume sprint interval and traditional endurance training in humans. J Physiol (Lond) 2008, 586:151-160.
39. Rakobowchuk M., Tanguay S., Burgomaster K., Howarth K., Gibala M., Macdonald M. Sprint interval and traditional endurance training induce similar improvements in peripheral arterial stiffness and flow-mediated dilation in healthy humans. Am J Physiol Regul Integr Comp Physiol 2008, 295:R236-R242.
40. Mirwald R., Baxter-Jones A.D.G., Bailey D., Beunen G. An assessment of maturity from anthropometric measurements. Med Sci Sports Exerc 2002, 34:689-694.
41. Taylor S.J., Whincup P.H., Hindmarsh P.C., Lampe F., Odoki K., Cook D.G. Performance of a new pubertal self-assessment questionnaire: a preliminary study. Paediatr Perinat Epidemiol 2001, 15:88-94.
42. Rosa J., Schwindt C., Oliver S., Leu S.Y., Flores R., Galassetti P. Exercise leukocyte profiles in healthy, type 1 diabetic, overweight, and asthmatic children. Pediatr Exerc Sci 2009, 21:19-33.
43. Pedersen B., Febbraio M. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 2008, 88:1379-1406.
44. Laursen E.M., Lanng S., Rasmussen M.H., Koch C., Skakkebaek N.E., Mller J. Normal spontaneous and stimulated GH levels despite decreased IGF-I concentrations in cystic fibrosis patients. Eur J Endocrinol 1999, 140:315-321.
45. Vanhelder W.P., Goode R.C., Radomski M.W. Effect of anaerobic and aerobic exercise of equal duration and work expenditure on plasma growth hormone levels. Eur J Appl Physiol Occup Physiol 1984, 52:255-257.
46. Bang P., Brandt J., Degerblad M., Enberg G., Kaijser L., Thorn M., et al. Exercise-induced changes in insulin-like growth factors and their low molecular weight binding protein in healthy subjects and patients with growth hormone deficiency. Eur J Clin Invest 1990, 20:285-292.
47. Park M.C., Jung S.J., Park Y.B., Lee S.K. Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis. Scand J Rheumatol 2008, 37:173-178.
48. Timmons B.W., Tarnopolsky M.A., Snider D., Bar-Or O. Immunological changes in response to exercise: influence of age, puberty, and gender. Med Sci Sports Exerc 2006, 38:293-304.
49. Kadoglou N.P.E., Iliadis F., Angelopoulou N., Perrea D., Ampatzidis G., Liapis C., et al. The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus. Eur J Cardiovasc Prev Rehabil 2007, 14:837-843.
50. Ploeger H., Takken T., de Greef M.H.G., Timmons B. The effects of acute and chronic exercise on inflammatory markers in children and adults with a chronic inflammatory disease: a systematic review. Exerc Immunol Rev 2009, 15:6-41.
51. Schneiderman-Walker J., Pollock S.L., Corey M., Wilkes D.D., Canny G.J., Pedder L., et al. A randomized controlled trial of a 3-year home exercise program in cystic fibrosis. J Pediatr 2000, 136:304-310.
52. Z-score Data Files Centers for Disease Control and Prevention, Available from, [cited 2010 Jun 10]. http://www.cdc.gov/growthcharts/zscore.htm.
53. Wang X., Dockery D.W., Wypij D., Fay M.E., Ferris B.G. Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol 1993, 15:75-88.